DOYLESTOWN, Pa., Jan. 07, 2020 (GLOBE NEWSWIRE) -- Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical company specializing in the research and development of cannabinoid therapeutics, announced today the receipt of a designated International Nome...

[New York] – EpiVax Oncology, Inc, today announced that it has scheduled a company presentation at Biotech Showcase™ 2020, to be held January 13–15, during the most important week in healthcare at the Hilton San Francisco Union Square. Gad Berdugo, CEO will present at Biotech ...

January 7, 2020 -- Nantes, France – InFlectis BioScience SAS, a drug discovery company committed to the development of innovative therapeutics harnessing the Integrated Stress Response for the treatment of a broad range of diseases, today announced the results of its Phase 1 s...

Chicago, Il. January 8, 2020: Content Carnivores, LLC, a creative marketing firm deploying proprietary technology, category and creative expertise in regulated industries is supporting 10 clients who are participating at the Biotech Showcase™ 2020, investor conference and/or o...

Oxidien Pharmaceuticals, a clinical-stage biopharmaceutical company developing a best-in-class enzyme therapeutic for an unmet kidney disease indication, today announced that it will present at Biotech Showcase™ 2020, to be held January 13–15, 2020 at the Hilton San Francisco ...

As New Mexico celebrates its 108th anniversary of statehood, a new Emerson College Poll finds New Mexico Democratic primary voters split between Senator Bernie Sanders at 28% and former V.P. Joe Biden at 27%. Entrepreneur Andrew Yang is the only other candidate in double figur...

January 6, 2020 -- AIM Biotech announced that its founder, Professor Roger Kamm, was awarded The Shu Chien Scientific Achievement Award. The award was granted by the Biomedical Engineering Society's Cellular and Molecular Bioengineering SIG in recognition of Prof Kamm's contri...

QuaraSense™ is an entirely new technology platform that will measure the signature of infectious bacteria, enabling rapid response and greater chance for stopping an infection. Treatment efficacy may be measured on an ongoing basis.  This will also be the first platform capab...

Holliston, MA – January 2, 2020 – Biostage, Inc. (OTCQB: BSTG) (“Biostage” or the “Company”), a bioengineering company developing next-generation esophageal implants, received the anticipated formal response from the U.S. Food and Drug Administration (FDA) related to the Compa...

Boston, MA -- January 5, 2020 -- Techlobe raised $24 million in a Series B financing, The round was led by Prospect Bay Ventures with participation from existing investors. Techlobe offers you great new ways to manage all the noise in life to effectively navigate the world in ...